Total Payments
$12,338
2024 Payments
$1,625
Companies
49
Transactions
640
Medicare Patients
3,488
Medicare Billing
$972,574
Payment Breakdown by Category
Food & Beverage$10,746 (87.1%)
Consulting$1,500 (12.2%)
Education$92.18 (0.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,746 | 637 | 87.1% |
| Consulting Fee | $1,500 | 1 | 12.2% |
| Education | $92.18 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $3,405 | 104 | $0 (2024) |
| ABBVIE INC. | $2,656 | 150 | $0 (2024) |
| Janssen Biotech, Inc. | $1,264 | 79 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,247 | 76 | $0 (2024) |
| PFIZER INC. | $376.76 | 24 | $0 (2024) |
| Gilead Sciences, Inc. | $273.31 | 9 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $210.00 | 10 | $0 (2017) |
| Allergan Inc. | $204.69 | 18 | $0 (2019) |
| Synergy Pharmaceuticals Inc | $180.72 | 11 | $0 (2018) |
| Romark Laboratories, LC | $173.19 | 16 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,625 | 101 | ABBVIE INC. ($401.10) |
| 2023 | $1,714 | 93 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($404.48) |
| 2022 | $1,398 | 83 | ABBVIE INC. ($421.05) |
| 2021 | $1,359 | 78 | AbbVie Inc. ($570.60) |
| 2020 | $732.86 | 46 | Takeda Pharmaceuticals U.S.A., Inc. ($193.25) |
| 2019 | $1,206 | 79 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($257.75) |
| 2018 | $3,075 | 93 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($1,900) |
| 2017 | $1,227 | 67 | AbbVie, Inc. ($272.45) |
All Payment Transactions
640 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Immunology | ||||||
| 12/05/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/04/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $9.57 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/26/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: LIVER DISEASE | ||||||
| 11/07/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Immunology | ||||||
| 10/21/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/10/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $8.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Gastroenterology | ||||||
| 10/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 591 | 14,871 | $1.7M | $312,831 |
| 2022 | 16 | 659 | 15,322 | $1.8M | $335,828 |
| 2021 | 19 | 892 | 9,026 | $1.5M | $232,225 |
| 2020 | 17 | 1,346 | 2,004 | $601,321 | $91,689 |
Total Patients
3,488
Total Services
41,223
Medicare Billing
$972,574
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 24 | 12,900 | $670,800 | $222,942 | 33.2% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 15 | 1,360 | $314,160 | $35,836 | 11.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 55 | 55 | $78,430 | $10,746 | 13.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 91 | 91 | $136,186 | $8,188 | 6.0% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 61 | 66 | $219,579 | $6,106 | 2.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 104 | 108 | $127,818 | $4,922 | 3.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 20 | 20 | $21,616 | $3,389 | 15.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 31 | $10,788 | $2,607 | 24.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $10,840 | $2,251 | 20.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $11,390 | $2,212 | 19.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 15 | 24 | $24,000 | $2,199 | 9.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 40 | $9,480 | $2,191 | 23.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $25,500 | $2,169 | 8.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 24 | 43 | $9,589 | $1,939 | 20.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 11 | 12 | $12,903 | $1,867 | 14.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 33 | 48 | $6,288 | $1,785 | 28.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 18 | 19 | $18,223 | $1,483 | 8.1% |
| J3380 | Injection, vedolizumab, 1 mg | Office | 2022 | 27 | 13,200 | $686,400 | $230,230 | 33.5% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2022 | 15 | 1,450 | $334,950 | $41,253 | 12.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 62 | 62 | $88,412 | $11,635 | 13.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 97 | 97 | $130,428 | $9,709 | 7.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 45 | 73 | $73,000 | $7,236 | 9.9% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 66 | 67 | $214,414 | $5,769 | 2.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 120 | 127 | $142,748 | $5,743 | 4.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 33 | 33 | $20,130 | $4,899 | 24.3% |
About Dr. John Day, M.D
Dr. John Day, M.D is a Gastroenterology healthcare provider based in Alabaster, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649213182.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Day, M.D has received a total of $12,338 in payments from pharmaceutical and medical device companies, with $1,625 received in 2024. These payments were reported across 640 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($10,746).
As a Medicare-enrolled provider, Day has provided services to 3,488 Medicare beneficiaries, totaling 41,223 services with total Medicare billing of $972,574. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Alabaster, AL
- Active Since 06/13/2006
- Last Updated 12/04/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1649213182
Products in Payments
- XIFAXAN (Drug) $3,176
- STELARA (Biological) $1,162
- ENTYVIO (Biological) $621.54
- LINZESS (Drug) $521.08
- HUMIRA (Biological) $420.87
- Humira (Biological) $399.84
- CREON (Drug) $394.55
- XELJANZ (Drug) $364.72
- VIBERZI (Drug) $275.32
- Entyvio (Biological) $274.61
- RINVOQ (Biological) $267.08
- Amitiza (Drug) $254.23
- MAVYRET (Drug) $235.49
- TRULANCE (Drug) $184.04
- Trulance (Drug) $180.72
- DIFICID (Drug) $172.86
- Cimzia (Drug) $163.30
- UCERIS (Drug) $163.11
- MOTEGRITY (Drug) $148.49
- DUPIXENT (Biological) $146.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Alabaster
Robert Loudon, M.d, M.D
Gastroenterology — Payments: $11,320
Gastroenterology $11,320
Brian Brunson, Md, MD
Gastroenterology — Payments: $8,818
Gastroenterology $8,818
Robert Marks, M.d, M.D
Gastroenterology — Payments: $8,475
Gastroenterology $8,475
Bradley Rubery, M.d, M.D
Gastroenterology — Payments: $4,483
Gastroenterology $4,483
Leonard Ou-Tim, Md, MD
Gastroenterology — Payments: $62.80
Gastroenterology $62.80